{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:47Z","timestamp":1740107327883,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T00:00:00Z","timestamp":1621123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T00:00:00Z","timestamp":1621123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00415-021-10594-7","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T17:02:32Z","timestamp":1621184552000},"page":"4796-4808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis"],"prefix":"10.1007","volume":"268","author":[{"given":"Franziska E.","family":"Hildesheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph H. B.","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-0433","authenticated-orcid":false,"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,16]]},"reference":[{"key":"10594_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116607","volume":"211","author":"M Nemy","year":"2020","unstructured":"Nemy M, Cedres N, Grothe MJ, Muehlboeck JS, Lindberg O, Nedelska Z et al (2020) Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. Neuroimage 211:116607","journal-title":"Neuroimage"},{"issue":"4","key":"10594_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JAD-180133","volume":"69","author":"P Koulousakis","year":"2019","unstructured":"Koulousakis P, Andrade P, Visser-Vandewalle V, Sesia T (2019) The nucleus basalis of meynert and its role in deep brain stimulation for cognitive disorders: a historical perspective. J Alzheimer\u2019s Dis 69(4):905\u2013919","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"18","key":"10594_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1002\/cne.23415","volume":"521","author":"M Mesulam","year":"2013","unstructured":"Mesulam M (2013) Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer`s disease. J Comp Neurol 521(18):4124\u20134144","journal-title":"J Comp Neurol"},{"issue":"2","key":"10594_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","volume":"221","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) The cholinergic system in Parkinson\u2019s disease. Behav Brain Res 221(2):564\u2013573","journal-title":"Behav Brain Res"},{"key":"10594_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cne.902140206","volume":"214","author":"M Mesulam","year":"1983","unstructured":"Mesulam M, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170\u2013197","journal-title":"J Comp Neurol"},{"issue":"5","key":"10594_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz J, Pagano G, Fern\u00e1ndez Bonfante JA, Wilson H, Politis M (2018) Nucleus Basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain 141(5):1501\u20131516","journal-title":"Brain"},{"issue":"10","key":"10594_CR7","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1007\/s12035-019-1588-0","volume":"56","author":"SY Shu","year":"2019","unstructured":"Shu SY, Jiang G, Zheng Z, Ma L, Wang B, Zeng Q et al (2019) A new neural pathway from the ventral striatum to the nucleus Basalis of Meynert with functional implication to learning and memory. Mol Neurobiol 56(10):7222\u20137233","journal-title":"Mol Neurobiol"},{"issue":"12","key":"10594_CR8","first-page":"2039","volume":"40","author":"KD Jethwa","year":"2019","unstructured":"Jethwa KD, Dhillon P, Meng D, Auer DP (2019) Are linear measurements of the nucleus basalis of Meynert suitable as a diagnostic biomarker in mild cognitive impairment and Alzheimer disease? Am J Neuroradiol 40(12):2039\u20132044","journal-title":"Am J Neuroradiol"},{"issue":"7","key":"10594_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2174\/1871527313666140917121132","volume":"13","author":"AM Tata","year":"2014","unstructured":"Tata AM, Velluto L, D'Angelo C, Reale M (2014) Cholinergic system dysfunction and neurodegenerative diseases: cause or effect? CNS Neurol Disord Drug Targets 13(7):1294\u20131303","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5","key":"10594_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/mds.27988","volume":"35","author":"M Gang","year":"2020","unstructured":"Gang M, Baba T, Hosokai Y, Nishio Y, Kikuchi A, Hirayama K et al (2020) Clinical and cerebral metabolic changes in Parkinson\u2019s disease with basal forebrain atrophy. Mov Disord 35(5):825\u2013832","journal-title":"Mov Disord"},{"issue":"1","key":"10594_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10146-y","volume":"7","author":"DH Hepp","year":"2017","unstructured":"Hepp DH, Foncke EMJ, Berendse HW, Wassenaar TM, Olde Dubbelink KTE, Groenewegen HJ et al (2017) Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson\u2019s disease patients with visual hallucinations. Sci Rep 7(1):1\u201310","journal-title":"Sci Rep"},{"key":"10594_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","volume":"32","author":"NI Bohnen","year":"2012","unstructured":"Bohnen NI, Mueller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S et al (2012) Heterogeneity of cholinergic denervation in Parkinson\u2019s disease without dementia. J Cereb Blood Flow Metab 32:1609\u20131617","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"10594_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JAD-150063","volume":"48","author":"K Brueggen","year":"2015","unstructured":"Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ et al (2015) Basal forebrain and hippocampus as predictors of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment-a multicenter DTI and volumetry study. J Alzheimer\u2019s Dis 48(1):197\u2013204","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"9","key":"10594_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hbm.21111","volume":"32","author":"SJ Teipel","year":"2011","unstructured":"Teipel SJ, Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF et al (2011) The cholinergic system in mild cognitive impairment and Alzheimer\u00b4s disease: an in vivo MRI and DTI study. Hum Brain Mapp 32(9):1349\u20131362","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10594_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"1","key":"10594_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuroimage.2011.07.045","volume":"59","author":"R Zivadinov","year":"2012","unstructured":"Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR et al (2012) Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis. A case-control study. Neuroimage 59(1):331\u2013339","journal-title":"Neuroimage"},{"key":"10594_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.12.004","volume":"90","author":"MG Dwyer","year":"2014","unstructured":"Dwyer MG, Bergsland N, Zivadinov R (2014) Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model. Neuroimage 90:207\u2013217","journal-title":"Neuroimage"},{"key":"10594_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","volume":"56","author":"B Patenaude","year":"2011","unstructured":"Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907\u2013922","journal-title":"Neuroimage"},{"issue":"11","key":"10594_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1177\/1352458513478675","volume":"19","author":"RHB Benedict","year":"2013","unstructured":"Benedict RHB, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B et al (2013) Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Mult Scler J 19(11):1478\u20131484","journal-title":"Mult Scler J"},{"issue":"55","key":"10594_CR20","first-page":"1","volume":"12","author":"RHB Benedict","year":"2012","unstructured":"Benedict RHB, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S et al (2012) Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol 12(55):1\u20138","journal-title":"BMC Neurol"},{"issue":"5","key":"10594_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RHB Benedict","year":"2017","unstructured":"Benedict RHB, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R et al (2017) Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 23(5):721\u2013733","journal-title":"Mult Scler"},{"key":"10594_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fneur.2019.00261","volume":"10","author":"B Brochet","year":"2019","unstructured":"Brochet B, Ruet A (2019) Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol 10:261","journal-title":"Front Neurol"},{"key":"10594_CR23","doi-asserted-by":"crossref","unstructured":"Lope-Piedrafita S (2018) Diffusion tensor imaging (DTI). In: Garcia-Martin ML, Lopez-Larrubia P (eds) Preclinical MRI: methods and protocols, methods in molecular biology, pp 103\u2013116","DOI":"10.1007\/978-1-4939-7531-0_7"},{"issue":"3","key":"10594_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1006\/nimg.2002.1267","volume":"17","author":"SK Song","year":"2002","unstructured":"Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17(3):1429\u20131436","journal-title":"Neuroimage"},{"issue":"14","key":"10594_CR25","doi-asserted-by":"publisher","first-page":"E1348","DOI":"10.1212\/WNL.0000000000008198","volume":"93","author":"AJC Eijlers","year":"2019","unstructured":"Eijlers AJC, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Pouwels PJW et al (2019) Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis. Neurology 93(14):E1348\u2013E1359","journal-title":"Neurology"},{"issue":"2","key":"10594_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp-2018-318440","volume":"90","author":"T Charalambous","year":"2018","unstructured":"Charalambous T, Tur C, Prados F, Kanber B, Chard DT, Ourselin S et al (2018) Structural network disruption markers explain disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 90(2):219\u2013226","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10594_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuropharm.2005.10.013","volume":"50","author":"E Nizri","year":"2006","unstructured":"Nizri E, Hamra-Amitay Y, Sicsic C, Lavon I, Benner T (2006) Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors. Neuropharmacology 50:540\u2013547","journal-title":"Neuropharmacology"},{"issue":"1","key":"10594_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","volume":"23","author":"VA Pavlov","year":"2009","unstructured":"Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, Ochani K et al (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23(1):41\u201345","journal-title":"Brain Behav Immun"},{"key":"10594_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41598-018-19701-7","volume":"8","author":"M Reale","year":"2018","unstructured":"Reale M, Costantini E, Di Nicola M, D\u2019Angelo C, Franchi S, D\u2019Aurora M et al (2018) Butyrylcholinesterase and acetylcholinesterase polymorphisms in multiple sclerosis patients: implication in peripheral inflammation. Sci Rep 8:1319","journal-title":"Sci Rep"},{"key":"10594_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/187152491701170203181930","volume":"17","author":"M Di Bari","year":"2017","unstructured":"Di Bari M, Di Pinto G, Reale M, Mengod G, Tata AM (2017) Cholinergic system and neuroinflammation: implication in multiple sclerosis. Cent Nerv Syst Agents Med Chem 17:1\u20137","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10594_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/biomedicines8060153","volume":"8","author":"V Gatta","year":"2020","unstructured":"Gatta V, Mengod G, Reale M, Tata AM (2020) Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis. Biomedicines 8:153","journal-title":"Biomedicines"},{"key":"10594_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jns.2018.06.020","volume":"392","author":"CRN Polachini","year":"2018","unstructured":"Polachini CRN, Spanevello RM, Schetinger MRC, Morsch VM (2018) Cholinergic and purinergic systems: a key to multiple sclerosis? J Neurol Sci 392:8\u201321","journal-title":"J Neurol Sci"},{"key":"10594_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2005.08.021","volume":"245","author":"C Christodoulou","year":"2006","unstructured":"Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB (2006) Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245:127\u2013136","journal-title":"J Neurol Sci"},{"issue":"17","key":"10594_CR34","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e318218107a","volume":"76","author":"LB Krupp","year":"2011","unstructured":"Krupp LB, Christodoulou C, Melville P, Scherl WF, Pai LY, Muenz LR et al (2011) Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 76(17):1500\u20131507","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10594-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10594-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10594-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T04:48:35Z","timestamp":1635914915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10594-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10594"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10594-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2021,5,16]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Franziska Hildesheim, Tom Fuchs, Dejan Jakimovski, and Niels Bergsland have nothing to disclose. Ralph H. B. Benedict has received research support from Accorda, Novartis, Genzyme, Biogen Idec, and Mallinkrodt, and is on the speakers\u2019 bureau for EMD Serono, and consults for Biogen Idec, Genentech, Roche, Sanofi\/Genzyme, Takeda, NeuroCog Trials, and Novartis. Dr. Benedict also receives royalties for Psychological Assessment Resources. Robert Zivadinov received personal compensation from EMD Serono, Sanofi, Bristol Myers Squibb, Keystone Heart and Novartis for speaking and consultant fees. He received financial support for research activities from Novartis, Protembis, Bristol Myers Squibb, Keystone Heart, Mapi Pharma, V-WAVE Medical and Boston Scientific. Michael G. Dwyer has received consultant fees from Claret Medical and EMD Serono and research grant support from Novartis. Bianca Weinstock-Guttman received honoraria as a speaker and\/or as a consultant for Biogen Idec, EMD Serono, Genentech, Novartis, Mallinckrodt, Celgene, Abbvie. Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genentech, and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}